Brief: Uni-Bio Science Says Unit Entered Strategic Partnership Agreement
15/04/2020 10:55
April 15 (Reuters) - Uni-Bio Science Group Ltd 0690.HK :
* UNIT, SINOPHARM WEIQIDA PHARMACEUTICAL, AND SUZHOU YINGLI
PHARMACEUTICAL TECHNOLOGY ENTERED STRATEGIC PARTNERSHIP
AGREEMENT
* UNDER DEAL, SUZHOU YINGLI SHALL BE RESPONSIBLE FOR EARLY
DEVELOPMENT OF ACARBOSE ACTIVE INGREDIENT
* SINOPHARM WEIQIDA RESPONSIBLE FOR ACARBOSE API
INDUSTRIALIZATION
DEVELOPMENT, MANUFACTURING & SUPPLY
Source text for Eikon: ID:nHKS41B86X
Further company coverage: 0690.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsUni-Bio Science H1 revenue falls 12% on pricing changes
Brief: Uni-Bio Science Expects Net Profit Of Hk$30 Million For Six Months Ended June 2026
Brief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA